Press release
Neurogenetic Testing Market Poised for 13.5 % Growth, Set to Hit $21 Billion by 2029
How Is the Neurogenetic Testing Market Projected to Grow, and What Is Its Market Size?The market size for neurogenetic testing has expanded considerably in the last few years. Its expansion will continue, with an increase from $0.61 billion in 2024 to $0.7 billion in 2025, reflecting a compound annual growth rate (CAGR) of 13.9%. Factors contributing to the growth during the historic period include a surge in neurological disease cases, more intensive research in the life science sector, a rise in the occurrence of Parkinson's disease and cancer cases, and heightened awareness among healthcare practitioners.
The neurogenetic testing market is anticipated to experience significant expansion in the upcoming years, predicted to reach $1.16 billion by 2029, with a compound annual growth rate (CAGR) of 13.5%. This surge during the forecast period is due in part to a variety of factors including the broadening scope of applications in personalized medicine, an escalating prevalence of chronic ailments, a rising number of hospitals and diagnostic labs, and an increased interest in early disease identification. Key foreseeable trends for this period include advancements in technology, increased acceptance of non-invasive testing procedures, innovations in product development, strategic partnerships, and the introduction of new biomarkers for neurological disorders.
What Are the Forces Behind the Rapid Growth of the Neurogenetic Testing Market?
The neurogenetic testing market's growth is anticipated to be fueled by the increasing occurrence of neurological disorders. These disorders, defining any condition impacting the nervous system including the brain, spinal cord, and nerves, proliferate due to genetic predisposition, infections, trauma, toxins, autoimmune responses, and degeneration. Neurogenetic testing plays a crucial role in improving the detection, therapy, and management of neurological disorders by providing tailored insights into genetic risk factors, guiding therapeutic choices, and allowing individuals and families to make knowledgeable healthcare decisions, thus enhancing patient care and outcomes. As an illustration, the European Brain Council, a non-profit organization based in Belgium, reported in April 2022 that over 600 neurological diseases and approximately 300 psychiatric conditions globally affect millions, including 65 million suffering from epilepsy. In Europe, there are 10.5 million dementia patients, with forecasts showing an increase to 18.7 million by 2050. Consequently, the growing incidence of neurological disorders is predicted to stimulate the neurogenetic testing market's expansion.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16131&type=smp
Who Are the Major Industry Players Fueling Neurogenetic Testing Market Expansion?
Major companies operating in the neurogenetic testing market are Thermo Fisher Scientific Inc., Mayo Clinic, Roche Diagnostics Corporation, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Exact Sciences Corporation, Myriad Genetics Inc., BioReference Laboratories Inc., Connecticut Children's, Invitae Corp., Ambry Genetics Corporation, Fulgent Genetics Inc., Blueprint Genetics Inc., GeneDx LLC, Pacific Biosciences of California Inc., MedGenome Labs, CENTOGENE, Baylor Genetics, Victorian Clinical Genetics Services
Which Key Developments Are Influencing the Neurogenetic Testing Market?
Premier enterprises in the neurogenetic testing market are introducing inventive products like whole-genome sequencing to elevate the precision and breadth of genetic analysis. This enables a more exhaustive and tailored testing process for neurological conditions. Whole-genome sequencing (WGS) is an extensive method of genetic testing that dedicates to finding the entire DNA sequence of a person's full genome. For example, Nucleus Genomics, a company based in the US and specializes in genetic analysis, unveiled a DNA analysis product in March 2024. This platform equips individuals with a more in-depth insight into their genetic tendencies, helping them to make informed decisions about their health and wellness. By employing state-of-the-art technology and professional genetic consulting services, Nucleus Genomics is geared to transform the sphere of genetic testing comprehensively. The power of whole-genome sequencing is now made easily accessible to individuals, which is seen as a significant revolution in the area of genomic medicine.
How Is the Segmentation of the Neurogenetic Testing Market Defined?
The neurogenetic testing market covered in this report is segmented -
1) By Type: Microarray Analysis, Whole-Exome Sequencing (WES), Multiplex Ligation Dependent Probe Amplification (MLPA), Polymerase Chain Reaction (PCR) Tests, Other Types
2) By Disease: Rare Genetic Disorder, Cancer, Cystic Fibrosis, Sickle Cell Anemia, Duchenne Muscular Dystrophy, Thalassemia, Huntington's Disease, Fragile X Syndrome, Other Diseases
3) By End-Users: Hospitals, Specialty Clinics, Research Institutes, Diagnostics Laboratories
Subsegments:
1) By Microarray Analysis: Comparative Genomic Hybridization (CGH) Microarray, Single Nucleotide Polymorphism (SNP) Microarray, Gene Expression Microarray
2) By Whole-Exome Sequencing (WES): Targeted Exome Sequencing, Clinical Exome Sequencing, Research-Grade Exome Sequencing
3) By Multiplex Ligation Dependent Probe Amplification (MLPA): MLPA For Copy Number Variation, MLPA For Methylation Analysis, MLPA For Specific Disease Detection
4) By Polymerase Chain Reaction (PCR) Tests: Quantitative PCR (qPCR), Reverse Transcription PCR (RT-PCR), Digital PCR (dPCR)
5) By Other Types: Next-Generation Sequencing (NGS), Southern Blotting, Fluorescence In Situ Hybridization (FISH), Sanger Sequencing
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/neurogenetic-testing-global-market-report
What Is the Leading Region in the Neurogenetic Testing Market?
North America was the largest region in the neurogenetic testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurogenetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Neurogenetic Testing Global Market Report?
- Market Size Analysis: Analyze the Neurogenetic Testing Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Neurogenetic Testing Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Neurogenetic Testing Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Neurogenetic Testing Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16131
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neurogenetic Testing Market Poised for 13.5 % Growth, Set to Hit $21 Billion by 2029 here
News-ID: 3864405 • Views: …
More Releases from The Business Research Company

Global Acrylic Powder Market Worth $77.43 Billion by 2029, Growing at 7.5% CAGR
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Acrylic Powder Market Outlook: What Size And CAGR Are Anticipated By 2025?
In recent years, the market size of acrylic powder has experienced significant growth. It is projected to expand from $54.48 billion in 2024 to $57.94 billion in 2025, with a compound annual growth rate (CAGR) of 6.4%. Factors…

Toluene Derivatives Industry to Achieve $8.45 Billion Growth by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Toluene Derivatives Market Grow by 2025 in Terms of Size and Growth?
In recent times, the market size of toluene derivatives has considerably grown. The market is projected to rise from $5.98 billion in 2024 to $6.4 billion in 2025, with a compound annual growth rate (CAGR) of 7.0%.…

Sulfur Dioxide Market on Path to Hit $7.07 Billion by 2029 at 3.9% CAGR
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Sulfur Dioxide Market Outlook: What Size And CAGR Are Anticipated By 2025?
The sulfur dioxide market has seen a consistent growth in its size over the past few years. Projected to expand from $5.89 billion in 2024 to $6.08 billion in 2025, it is speculated to increase at a compound…

Release Agents Market to Surpass $1.35 Billion by 2029 | Key Trends & Insights
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Release Agents Market Grow by 2025 in Terms of Size and Growth?
The market size of release agents has seen significant growth in recent years. The market is projected to expand from a value of $1.06 billion in 2024 to $1.11 billion in 2025, with a compound annual growth…
More Releases for Neurogenetic
Emerging Trends to Drive Neurogenetic Testing Market Growth at 13.5% CAGR Throug …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Neurogenetic Testing Market Size Growth Forecast: What to Expect by 2025?
Recently, there has been a swift development in the neurogenetic testing market size. The market is set to expand from $0.61 billion in 2024 to $0.7 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 13.9%.…
Neurogenetic Testing Market Anticipated To Witness Robust Growth, Surpassing $1. …
The Neurogenetic Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Neurogenetic Testing Market Size and Its Estimated Growth Rate?
The neurogenetic testing market has seen fast growth. It will grow from $0.61 billion in 2024 to $0.7 billion in 2025 at…
Neurogenetic Testing Market Growth Outlook, Exploring Advances, Emerging Technol …
Overview of the Neurogenetic Testing Market
The global neurogenetic testing market has witnessed substantial growth over the past decade, driven by the increasing prevalence of neurological disorders with genetic origins and rapid advancements in genetic testing technologies. This growth is primarily propelled by rising awareness about hereditary neurological diseases such as Huntington's disease, amyotrophic lateral sclerosis (ALS), and various forms of hereditary epilepsy, coupled with increasing demand for personalized medicine…
Rising Prevalence Of Neurological Disorders Fuels Demand For Neurogenetic Testin …
Which drivers are expected to have the greatest impact on the over the neurogenetic testing market's growth?
The increasing prevalence of neurological disorders is also expected to propel the growth of the neurogenetic testing market. These disorders affect the nervous system and can arise from genetic factors, infections, trauma, or degeneration. Neurogenetic testing offers valuable insights into the genetic risk factors of these conditions, guiding treatment choices and improving patient care.…
Neurogenetic Testing Market Insights 2024: Emerging Technologies and Global Expa …
"The Business Research Company recently released a comprehensive report on the Global Neurogenetic Testing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Neurogenetic Testing Market: Size, Share, Competitive Landscape, Current Industr …
The Neurogenetic Testing market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with development…